{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:24:45Z","timestamp":1788225885981,"version":"build-2803163510"},"reference-count":55,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T00:00:00Z","timestamp":1459296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>\n                    Minimal change disease (MCD) is an important cause of nephrotic syndrome and is characterized by massive proteinuria and hypoalbuminemia, resulting in edema and hypercholesterolemia. The podocyte plays a key role in filtration and its disruption results in a dramatic loss of function leading to proteinuria. Immunologic disturbance has been suggested in the pathogenesis of MCD. Because of its clinical features, such as recurrent relapse\/remission course, steroid response in most patients, and rare familial cases, a genetic defect has been thought to be less likely in MCD. Recent progress in whole-exome sequencing reveals pathogenic mutations in familial cases in steroid-sensitive nephrotic syndrome (SSNS) and sheds light on possible mechanisms and key molecules in podocytes in MCD. On the other hand, in the majority of cases, the existence of circulating permeability factors has been implicated along with T lymphocyte dysfunction. Observations of benefit with rituximab added B cell involvement to the disease. Animal models are unsatisfactory, and the humanized mouse may be a good model that well reflects MCD pathophysiology to investigate suggested \u201cT cell dysfunction\u201d directly related to podocytes\n                    <ns4:italic>in vivo<\/ns4:italic>\n                    . Several candidate circulating factors and their effects on podocytes have been proposed but are still not sufficient to explain whole mechanisms and clinical features in MCD. Another circulating factor disease is focal segmental glomerulosclerosis (FSGS), and it is not clear if this is a distinct entity, or on the same spectrum, implicating the same circulating factor(s). These patients are mostly steroid resistant and often have a rapid relapse after transplantation. In clinical practice, predicting relapse or disease activity and response to steroids is important and is an area where novel biomarkers can be developed based on our growing knowledge of podocyte signaling pathways. In this review, we discuss recent findings in genetics and podocyte biology in MCD.\n                  <\/ns4:p>","DOI":"10.12688\/f1000research.7300.1","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T05:46:58Z","timestamp":1459316818000},"page":"412","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Cell biology and genetics of minimal change disease"],"prefix":"10.12688","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-4518","authenticated-orcid":false,"given":"Moin A.","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"1266-71","DOI":"10.1093\/ndt\/gfu363","article-title":"One hundred ways to kill a podocyte.","volume":"30","author":"M Saleem","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"163-71","DOI":"10.1038\/kisup.2012.16","article-title":"Chapter 3: Steroid-sensitive nephrotic syndrome in children.","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"556-60","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function.","volume":"2","author":"R Shalhoub","year":"1974","journal-title":"Lancet."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"699-709","DOI":"10.1007\/s00467-012-2239-0","article-title":"New developments in steroid-resistant nephrotic syndrome.","volume":"28","author":"M Saleem","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1342-8","DOI":"10.1681\/ASN.2013080852","article-title":"Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence.","volume":"25","author":"W Ding","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"561-4","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.","volume":"98","year":"1981","journal-title":"J Pediatr."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"415-26","DOI":"10.1007\/s00281-007-0094-z","article-title":"Minimal change nephropathy and focal segmental glomerulosclerosis.","volume":"29","author":"P Mathieson","year":"2007","journal-title":"Semin Immunopathol."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"159-65","DOI":"10.1038\/ki.1978.23","article-title":"Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children.","volume":"13","year":"1978","journal-title":"Kidney Int."},{"key":"ref-9","doi-asserted-by":"crossref","first-page":"769-76","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.","volume":"8","author":"P Tarshish","year":"1997","journal-title":"J Am Soc Nephrol."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"592-600","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.","volume":"10","author":"A Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"1279-89","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.","volume":"26","author":"C Sadowski","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"637-48","DOI":"10.2215\/CJN.07200712","article-title":"Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome.","volume":"8","author":"H McCarthy","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"884-90","DOI":"10.1016\/j.ajhg.2014.04.010","article-title":"Mutations in EMP2 cause childhood-onset nephrotic syndrome.","volume":"94","author":"H Gee","year":"2014","journal-title":"Am J Hum Genet."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"98-112","DOI":"10.1038\/nrm3512","article-title":"Caveolae as plasma membrane sensors, protectors and organizers.","volume":"14","author":"R Parton","year":"2013","journal-title":"Nat Rev Mol Cell Biol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"4965-77","DOI":"10.2147\/DDDT.S77646","article-title":"Lipopolysaccharide-induced caveolin-1 phosphorylation-dependent increase in transcellular permeability precedes the increase in paracellular permeability.","volume":"9","author":"N Wang","year":"2015","journal-title":"Drug Des Devel Ther."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"2375-84","DOI":"10.1172\/JCI79504","article-title":"KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.","volume":"125","author":"H Gee","year":"2015","journal-title":"J Clin Invest."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"3243-53","DOI":"10.1172\/JCI69134","article-title":"ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.","volume":"123","author":"H Gee","year":"2013","journal-title":"J Clin Invest."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"2732-9","DOI":"10.1681\/ASN.2006121346","article-title":"A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells.","volume":"18","author":"A Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"73-6","DOI":"10.1159\/000185246","article-title":"Effect of supernatants derived from T lymphocyte culture in minimal change nephrotic syndrome on rat kidney capillaries.","volume":"51","author":"K Maruyama","year":"1989","journal-title":"Nephron."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"2233-41","DOI":"10.1007\/s00467-012-2248-z","article-title":"DNA methylation changes between relapse and remission of minimal change nephrotic syndrome.","volume":"27","author":"Y Kobayashi","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"e30523","DOI":"10.1371\/journal.pone.0030523","article-title":"Upregulation of nuclear factor-related kappa B suggests a disorder of transcriptional regulation in minimal change nephrotic syndrome.","volume":"7","author":"V Audard","year":"2012","journal-title":"PLoS One."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1691-8","DOI":"10.1007\/s00467-009-1214-x","article-title":"T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.","volume":"24","author":"C Araya","year":"2009","journal-title":"Pediatr Nephrol."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"332-45","DOI":"10.1159\/000350161","article-title":"The role of Th17\/IL-17 in the pathogenesis of primary nephrotic syndrome in children.","volume":"37","author":"L Wang","year":"2013","journal-title":"Kidney Blood Press Res."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"314-20","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome.","volume":"139","author":"L Liu","year":"2011","journal-title":"Clin Immunol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"4080-5","DOI":"10.1073\/pnas.1418316112","article-title":"Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.","volume":"112","author":"L Schewitz-Bowers","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"1701-10","DOI":"10.1681\/ASN.2014030247","article-title":"HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome.","volume":"26","author":"R Gbadegesin","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"1273-81","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.","volume":"384","author":"K Iijima","year":"2014","journal-title":"Lancet."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"851-6","DOI":"10.1093\/ndt\/gft312","article-title":"Rituximab for minimal change disease in adults: long-term follow-up.","volume":"29","author":"A Bruchfeld","year":"2014","journal-title":"Nephrol Dial Transplant."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"277-82","DOI":"10.1159\/000368590","article-title":"Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.","volume":"128","author":"A Kronbichler","year":"2014","journal-title":"Nephron Clin Pract."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"214-8","DOI":"10.1016\/j.autrev.2008.07.048","article-title":"Altered B-cell signaling in lupus.","volume":"8","author":"K Liu","year":"2009","journal-title":"Autoimmun Rev."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"1639-48","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus.","volume":"189","author":"O Chan","year":"1999","journal-title":"J Exp Med."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"501-13","DOI":"10.1002\/art.20858","article-title":"Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.","volume":"52","author":"P Sfikakis","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"1147-50","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab.","volume":"112","author":"R Stasi","year":"2008","journal-title":"Blood."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.","volume":"3","author":"A Fornoni","year":"2011","journal-title":"Sci Transl Med."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"629-37","DOI":"10.1681\/ASN.2004030172","article-title":"Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes.","volume":"16","author":"R Coward","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"1410-5","DOI":"10.1007\/s00467-005-1936-3","article-title":"Altered activity of plasma hemopexin in patients with minimal change disease in relapse.","volume":"20","author":"W Bakker","year":"2005","journal-title":"Pediatr Nephrol."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"2140-9","DOI":"10.1681\/ASN.2007080940","article-title":"Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.","volume":"19","author":"R Lennon","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"P1-10","DOI":"10.1159\/000075574","article-title":"Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells.","volume":"96","author":"J Kapojos","year":"2004","journal-title":"Nephron Physiol."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"603-10","DOI":"10.1111\/j.1523-1755.2005.00438.x","article-title":"Protease activity of plasma hemopexin.","volume":"68","author":"W Bakker","year":"2005","journal-title":"Kidney Int."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"7766-74","DOI":"10.1158\/0008-5472.CAN-05-3897","article-title":"Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.","volume":"66","author":"T Goerge","year":"2006","journal-title":"Cancer Res."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"660-71","DOI":"10.1002\/path.4149","article-title":"Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1.","volume":"229","author":"J Harris","year":"2013","journal-title":"J Pathol."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"870-92","DOI":"10.1189\/jlb.1006629","article-title":"Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins.","volume":"81","author":"H Piccard","year":"2007","journal-title":"J Leukoc Biol."},{"key":"ref-43","doi-asserted-by":"publisher","DOI":"10.1038\/srep13647","article-title":"Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.","volume":"5","author":"M Alfano","year":"2015","journal-title":"Sci Rep."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"55-63","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor.","volume":"14","author":"C Wei","year":"2008","journal-title":"Nat Med."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"952-60","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.","volume":"17","author":"C Wei","year":"2011","journal-title":"Nat Med."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"649-58","DOI":"10.1038\/ki.2013.546","article-title":"Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.","volume":"85","author":"A Sinha","year":"2014","journal-title":"Kidney Int."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"641-8","DOI":"10.1038\/ki.2013.544","article-title":"A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.","volume":"85","author":"T Wada","year":"2014","journal-title":"Kidney Int."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"1363-71","DOI":"10.1007\/s00467-013-2679-1","article-title":"CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.","volume":"29","author":"G Cara-Fuentes","year":"2014","journal-title":"Pediatr Nephrol."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"1390-7","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome.","volume":"113","author":"J Reiser","year":"2004","journal-title":"J Clin Invest."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"296-302","DOI":"10.1038\/ki.2010.143","article-title":"Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.","volume":"78","author":"E Garin","year":"2010","journal-title":"Kidney Int."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"1803-12","DOI":"10.1007\/s00467-013-2498-4","article-title":"Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes.","volume":"28","author":"T Ishimoto","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"F335-41","DOI":"10.1152\/ajprenal.00510.2015","article-title":"Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?","volume":"310","author":"R Novelli","year":"2016","journal-title":"Am J Physiol Renal Physiol."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"2163-6","DOI":"10.1007\/s00467-012-2218-5","article-title":"The phenomenon of focal segmental glomerulosclerosis post-transplantation--a one-hit wonder?","volume":"27","author":"M Saleem","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"2217-26","DOI":"10.1007\/s00467-012-2163-3","article-title":"TNF\u03b1 pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and \u03b23 integrin activation.","volume":"27","author":"M Bitzan","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"516-20","DOI":"10.1007\/s00467-003-1122-4","article-title":"Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome.","volume":"18","author":"A Bakr","year":"2003","journal-title":"Pediatr Nephrol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/5-412\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-412\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-412\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T12:52:49Z","timestamp":1655383969000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/5-412\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":55,"URL":"https:\/\/doi.org\/10.12688\/f1000research.7300.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.7868.r13095","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.7868.r13096","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.7868.r13096","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.7868.r13095","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/5-412\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.7868.r13095, Annette Bruchfeld, Department of Renal Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 30 Mar 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-412\/v1#referee-response-13095","order":0,"name":"referee-response-13095","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.7868.r13096, Vincent Audard, Centre de R\u00e9f\u00e9rence Syndrome N\u00e9phrotique Idiopathique INSERM U955, Service de N\u00e9phrologie et Transplantation, CHU Henri Mondor, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, Paris, France, 30 Mar 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-412\/v1#referee-response-13096","order":1,"name":"referee-response-13096","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}